COPHARM12
Pharmaceutical Innovations for Sustainable Healthcare
April 15-16, 2026
General Instructions for Authors – Manuscript Submission
1-Eligibility and Originality
Manuscripts must report original, unpublished research and must be relevant to one of the declared conference scientific tracks
Simultaneous submission to other conferences or journals is strictly prohibited unless clearly disclosed at the time of submission.
All submissions must be free from plagiarism, data fabrication, falsification, or inappropriate image manipulation.
2-Manuscript Type and Length
Authors should submit full-length original research articles.
- Word count: 4,000–8,000 words (excluding references)
- Required manuscript sections:
- Title
- Authors’ Names and Affiliations
- Abstract (200–300 words)
- Keywords (4–6)
- Introduction
- Materials and Methods
- Results
- Discussion
- Conclusion
- Acknowledgments (if applicable)
- Funding Statement
- Conflict of Interest Statement
- References
- Tables and Figures
3-Language and Style
- Manuscripts must be written in clear, professional English (British or American English; consistency required).
- Authors are responsible for language editing and proofreading before submission.
- Manuscripts with poor language quality may be returned for revision or desk-rejected.
4. Formatting Guidelines
- File format: Microsoft Word (.docx)
- Font: Times New Roman, 12 pt
- Line spacing: Single or 1.5
- Paper size: A4
- Margins: 2.5 cm on all sides
Figures and Tables
- Must be embedded in the text at appropriate locations
- High resolution and clearly readable
- Numbered consecutively and provided with descriptive captions
- Images must not be manipulated beyond acceptable brightness/contrast adjustments
- Previously published figures require written permission and proper citation
References
- Use Vancouver style
- References must be numbered consecutively in order of first appearance in the text
Title Page
A separate title page must be submitted containing:
- Full names of all authors
- Institutional affiliations
- Corresponding author clearly identified
- Email address and ORCID ID (if available)
5. Ethical Requirements
Authors must declare that:
- The manuscript is original and free from plagiarism or misconduct
- All authors have approved the final version
- All ethical standards have been followed
Human and Animal Studies
- Studies involving humans or animals must include:
- Name of the ethics committee
- Approval number/code
- Date of approval
- Human studies must comply with the Declaration of Helsinki
- Animal studies must follow international ethical guidelines (e.g., ARRIVE or institutional standards)
- Informed consent must be stated where applicable
6. Plagiarism and Similarity Check
- All manuscripts will be screened using plagiarism detection software.
- The acceptable similarity index must not exceed 15–20%, excluding references.
- Self-plagiarism is not permitted.
- Manuscripts exceeding the acceptable limit will be rejected without review.
7. Authorship and Contributions
- All listed authors must have made significant scientific contributions to the work.
- An author contribution statement is required or strongly recommended.
- Changes in authorship (addition, removal, or order) after submission are not allowed without written consent from all authors.
8. Funding and Conflict of Interest
- All sources of financial support or sponsorship must be disclosed.
- If no funding was received, authors should state:
“This research received no specific grant from any funding agency.” - Authors must declare any financial or non-financial conflicts of interest.
- If none exist, include:
“The authors declare no conflict of interest.”
9. Data Availability and Transparency
- Authors must retain original data and provide it upon request.
- A data availability statement is encouraged, indicating whether data are publicly available, restricted, or available upon reasonable request.
10. Supplementary Materials
- Supplementary files (additional data, figures, or protocols) may be submitted.
- Supplementary materials will be reviewed but may not appear in printed proceedings.
11. Submission Process
Manuscripts must be submitted through one of the following methods:
- Via the conference website submission portal (Indico system):
https://conf.copharm.uobaghdad.edu.iq - Or by email to the Scientific Committee (refer to the website for the official email address)
Cover Letter
Each submission must include a cover letter stating:
- The novelty and scientific significance of the work
- Relevance to the conference themes
- Disclosure of any conflicts of interest
Deadline
- Full manuscript submission deadline: March 15, 2026
(Deadlines may be updated on the conference website; abstract deadlines for presentations may differ.)
12. Peer Review Process
- All submissions will undergo peer review by the Scientific Committee.
- The review process may be single-blind or double-blind (as determined by the conference).
- Authors may be requested to revise manuscripts in response to reviewers’ comments within a specified timeframe.
- Editorial decisions are final.
13. Acceptance, Registration, and Presentation
- Acceptance of a manuscript is conditional upon conference registration.
- At least one author must attend and present the paper.
- Failure to present may result in exclusion from the conference proceedings.
14. Publication Opportunity
Selected high-quality manuscripts may be invited for publication in special issues of affiliated journals, including Scopus- or Clarivate-indexed journals.
Journal-specific guidelines will be provided after acceptance.
15. Copyright and Disclaimer
- Upon acceptance, authors agree to transfer publication rights to the conference organizers.
- Authors retain the right to use their work for academic and educational purposes with proper citation.
- The conference organizers are not responsible for the accuracy of data or opinions expressed in submitted manuscripts.
16. Author Checklist (Before Submission)
- ☐ Manuscript follows formatting guidelines
- ☐ Abstract within word limit
- ☐ Ethics approval included (if applicable)
- ☐ Plagiarism check completed
- ☐ Conflict of interest declared
- ☐ Funding statement included
- ☐ References in Vancouver style
- ☐ Figures and tables properly labeled
- ☐ Cover letter attached
For the latest updates, templates, and announcements, please visit:
https://conf.copharm.uobaghdad.edu.iq
Strict compliance with these instructions is required to avoid desk rejection.
